Original document(12 pages)  中文版
    The present invention is dibutyrul adenosine cyclophosphate calcium and its hydrate in the molecular formula of C18H23N5O8P.1/2Ca.nH2O, where n=0-2 5 of different characters. Dibutyrul adenosine cyclophosphate calcium is slightly soluble in water at room temperature and insoluble in ethanol and has high storage stability. Dibutyrul adenosine cyclophosphate calcium and its hydrate are used as protein kinase activator for treating cardiac and cerebral vascular diseases mainly as well as in regulating growth of mammals.
Application Number
申请号		 200610153388 Application Date
申请日		 2006.09.15
Title 名称 Medicines of different characters and their prepn and use
Publication Number
公开号		 1931180 Publication Date
公开日		 2007.03.21
Approval Pub. Date Granted Pub. Date
International Classification 分类号 A61K31/7076;A61K9/14;A61K9/19;A61P9/00;A61P9/02;A61P9/04;A61P9/06;A61P9/10;A61P17/06;A61P29/00;A61P35/00;A61P7/02;A61P11/00;A61P1/16;A61P43/00
Applicant(s) Name
申请人		 Wuhan Anshi Medicine Sci-Tech Co., Ltd.
Address 地址
Inventor(s) Name 发明人
Attorney & Agent 代理人 huqing tang
More information 更  多  信  息


 Related patents information
Improved low-temperature energy source utilization process in caprolactam production
Chinese medicine preparation containing ophiopogon root total saponin and preparation method
Natural skin-care raw material-Saussurea involucrata extract of alcohol
Circular utilizing process for waste lixivium of tanning
Sliding-window-based SOAP message transfer method
Method of preparing zinc oxide doped ambient temperature diluted magnetic semi-conducting material
Equal-high segmenting combined numerical controlling milling manufacture method of complex shaped parts
A preparation method for the indoor temperature diluted magnetic semiconductor material of cobalt-doped TiO2
Dust-collection chamber of vacuum duster
Aspartic acid laumosaren hydrate, its production and use
Google
Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.